BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19944744)

  • 1. Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system.
    Wang X; Fan H; Ying Z; Li B; Wang H; Wang G
    Neurosci Lett; 2010 Jan; 469(1):112-6. PubMed ID: 19944744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of the degradation of aggregated TDP-43 mediated by the ubiquitin proteasome system and macroautophagy.
    Cascella R; Fani G; Capitini C; Rusmini P; Poletti A; Cecchi C; Chiti F
    FASEB J; 2017 Dec; 31(12):5609-5624. PubMed ID: 28842427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1.
    Brady OA; Meng P; Zheng Y; Mao Y; Hu F
    J Neurochem; 2011 Jan; 116(2):248-59. PubMed ID: 21062285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43.
    Urushitani M; Sato T; Bamba H; Hisa Y; Tooyama I
    J Neurosci Res; 2010 Mar; 88(4):784-97. PubMed ID: 19798749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species.
    Scotter EL; Vance C; Nishimura AL; Lee YB; Chen HJ; Urwin H; Sardone V; Mitchell JC; Rogelj B; Rubinsztein DC; Shaw CE
    J Cell Sci; 2014 Mar; 127(Pt 6):1263-78. PubMed ID: 24424030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells.
    Nonaka T; Arai T; Buratti E; Baralle FE; Akiyama H; Hasegawa M
    FEBS Lett; 2009 Jan; 583(2):394-400. PubMed ID: 19111550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Arai T; Hasegawa M; Akiyama H; Ikeda K; Nonaka T; Mori H; Mann D; Tsuchiya K; Yoshida M; Hashizume Y; Oda T
    Biochem Biophys Res Commun; 2006 Dec; 351(3):602-11. PubMed ID: 17084815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of heat shock factor 1 maintains TAR DNA binding protein 43 solubility via induction of inducible heat shock protein 70 in cultured cells.
    Lin PY; Folorunso O; Taglialatela G; Pierce A
    J Neurosci Res; 2016 Jul; 94(7):671-82. PubMed ID: 26994698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells.
    Cicardi ME; Cristofani R; Rusmini P; Meroni M; Ferrari V; Vezzoli G; Tedesco B; Piccolella M; Messi E; Galbiati M; Boncoraglio A; Carra S; Crippa V; Poletti A
    Sci Rep; 2018 Aug; 8(1):12390. PubMed ID: 30120266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43.
    Nonaka T; Kametani F; Arai T; Akiyama H; Hasegawa M
    Hum Mol Genet; 2009 Sep; 18(18):3353-64. PubMed ID: 19515851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin.
    Hiji M; Takahashi T; Fukuba H; Yamashita H; Kohriyama T; Matsumoto M
    Acta Neuropathol; 2008 Aug; 116(2):183-91. PubMed ID: 18584184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Component of ubiquitin-positive inclusions in ALS].
    Hasegawa M; Arai T
    Brain Nerve; 2007 Oct; 59(10):1171-7. PubMed ID: 17969358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing.
    Che MX; Jiang YJ; Xie YY; Jiang LL; Hu HY
    FASEB J; 2011 Jul; 25(7):2344-53. PubMed ID: 21450909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and mis-metabolism of the neuropathological signature protein TDP-43.
    Huang CC; Bose JK; Majumder P; Lee KH; Huang JT; Huang JK; Shen CK
    J Cell Sci; 2014 Jul; 127(Pt 14):3024-38. PubMed ID: 24860144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
    Prudlo J
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.
    Shen WC; Li HY; Chen GC; Chern Y; Tu PH
    Autophagy; 2015 Apr; 11(4):685-700. PubMed ID: 25484089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The molecular mechanisms of intracellular TDP-43 aggregates].
    Nonaka T; Arai T; Hasegawa M
    Brain Nerve; 2009 Nov; 61(11):1292-300. PubMed ID: 19938686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic TDP-43 impairs the activity of the ubiquitin-proteasome system.
    Yin P; Bai D; Zhu L; Deng F; Guo X; Li B; Chen L; Li S; Li XJ
    Exp Neurol; 2021 Nov; 345():113833. PubMed ID: 34363810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild type and mutant amyloid precursor proteins influence downstream effects of proteasome and autophagy inhibition.
    Cecarini V; Bonfili L; Cuccioloni M; Mozzicafreddo M; Rossi G; Keller JN; Angeletti M; Eleuteri AM
    Biochim Biophys Acta; 2014 Feb; 1842(2):127-34. PubMed ID: 24215712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.